Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial

European Radiology
Ning LvMing Zhao

Abstract

Pain is one of the most common side effects of transcatheter arterial chemoembolization (TACE) treatment. This study aimed to assess the analgesic effect of parecoxib sodium for postoperative pain control in patients with inoperable hepatocellular carcinoma (HCC) undergoing TACE. This randomized placebo-controlled prospective clinical study was conducted at a single cancer centre. Patients were randomly assigned to receive parecoxib sodium (experimental group; n = 60) or 0.9 % sodium chloride (control group; n = 60) 1 h before TACE and once every 12 h for 2 days after TACE. Pain level, morphine consumption, adverse events, and quality of life were evaluated and compared between the two groups. Pain scores, percentage distribution of pain categories, and morphine consumption were significantly lower in the experimental group than in the control group (P < 0.05). Fever score comparisons revealed significantly better body temperature balance in the experimental group than in the control group (P = 0.024). Quality-of-life scores in the experimental group were significantly better than those in the control group (P < 0.05). Our results demonstrate that the perioperative administration of parecoxib significantly improved its effectiv...Continue Reading

References

Aug 30, 2005·Annals of the Rheumatic Diseases·J ZochlingUNKNOWN European League Against Rheumatism
Aug 8, 2006·Gastroenterology·Kenichi TakayasuUNKNOWN Liver Cancer Study Group of Japan
Jul 17, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shigeki AriiMasatoshi Kudo
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Apr 5, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Kenji IkedaHiromitsu Kumada
Dec 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zhen-Wei PengWan Yee Lau
Mar 8, 2013·Journal of Vascular and Interventional Radiology : JVIR·Masafumi IkedaUNKNOWN Korea Interventional Radiology in Oncology Study Group (KIVROSG)

❮ Previous
Next ❯

Citations

May 7, 2019·Gut and Liver·UNKNOWN Korean Liver Cancer Association, UNKNOWN National Cancer Center
Jul 5, 2019·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·UNKNOWN Korean Liver Cancer Association (KLCA), UNKNOWN National Cancer Center (NCC), Goyang, Korea
Sep 4, 2019·Molecular Cancer·Zhiwei ChenShengtao Zhou
Sep 3, 2020·World Journal of Gastroenterology : WJG·Li-Fang BianYan Zheng
May 11, 2017·Cardiovascular and Interventional Radiology·Jan B HinrichsThomas Rodt
Aug 15, 2017·World Journal of Hepatology·Leung Li, Winnie Yeo
Jan 11, 2019·International Journal of Molecular Medicine·Jingru ZhaoLitao Li
May 16, 2020·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Danbee KangHyo Keun Lim
Feb 23, 2020·European Radiology·Steve HalliganSusan Mallett
Jul 21, 2021·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Kerstin WohlleberAndré L Mihaljevic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.